Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
MDA-MB-361
HER2amp
Luminal
AG1024
IGF1R
RTK
7506.066
uM
inf
inf
0.9368 0.9368 0.0000 0.0689
0.0388
1.1486
MDA-MB-361
HER2amp
Luminal
ICRF-193
TOP2
TOP
10999.151
uM
inf
inf
0.6771 0.6771 0.0000 0.0774
0.0387
0.7090
HCC1428
HR+
Luminal
ICRF-193
TOP2
TOP
11936.157
uM
inf
inf
0.7052 0.7052 0.0000 0.1856
-0.0376
0.9133
MDA-MB-361
HER2amp
Luminal
Cetuximab
EGFR
ErbB
7895.018
uM
inf
inf
0.9756 0.9756 0.0000 0.0240
-0.0375
1.2916
MDA-MB-134-VI
HR+
Luminal
FR180204
ERK1/2
MAPK
10519.137
uM
inf
inf
0.8748 0.8748 0.0000 0.0872
-0.0369
1.0772
BT-474
HER2amp
Luminal
Selumetinib
MEK
MAPK
12291.155
uM
inf
inf
0.8945 0.8945 0.0000 -0.0163
0.0368
0.4532
MDA-MB-175-VII
HR+
Luminal
ICRF-193
TOP2
TOP
10642.139
uM
inf
inf
0.8934 0.8934 0.0000 0.0557
-0.0365
0.7017
Hs 578T
TNBC
Basal B
FTase Inhibitor I
Ftase
MAPK
10694.154
uM
inf
inf
0.9764 0.9764 0.0000 -0.0084
-0.0364
2.3045
HCC1428
HR+
Luminal
PD184352
MEK
MAPK
11936.155
uM
inf
inf
0.9166 0.9166 0.0000 0.0264
-0.0360
0.7332
HCC1428
HR+
Luminal
PD184352
MEK
MAPK
11936.155
uM
inf
inf
0.9166 0.9166 0.0000 0.0264
-0.0360
0.7332
BT-474
HER2amp
Luminal
Glycyl-H-1152
ROCK2
12178.16
uM
inf
inf
0.7508 0.7508 0.0000 0.1609
0.0357
0.7392
MDA-MB-453
TNBC
Luminal
Sorafenib
PDGFR/VEGFR/KIT/FLT3
RTK
7517.084
uM
inf
inf
0.8484 0.8484 0.0000 0.1100
-0.0346
1.4076
MCF7
HR+
Luminal
Cetuximab
EGFR
ErbB
9583.026
uM
inf
inf
0.9966 0.9966 0.0000 0.0156
-0.0344
1.2731
HCC1419
HER2amp
Luminal
Sorafenib
PDGFR/VEGFR/KIT/FLT3
RTK
7437.084
uM
inf
inf
0.9273 0.9273 0.0000 0.1333
0.0343
0.4343
ZR-75-1
HR+
Luminal
FTase Inhibitor I
Ftase
MAPK
12003.167
uM
inf
inf
0.7304 0.7304 0.0000 0.2250
-0.0343
1.1158
600MPE
HR+
Luminal
GM6001
MMP
MMP
5898.096
uM
inf
inf
0.8794 0.8794 0.0000 0.0460
-0.0341
0.6718
MB 157
Unknown
Unknown
AG1024
IGF1R
RTK
7482.066
uM
inf
inf
1.0500 1.0500 0.0000 0.0332
-0.0335
1.1347
MDA-MB-468
TNBC
Basal A
Trametinib
MEK
MAPK
7906.012
uM
inf
inf
0.2629 0.2629 0.0000 0.1652
-0.0328
0.4916
SUM190PT
HER2amp
Luminal
Ribavirin
15358.211
uM
inf
inf
1.0036 1.0036 0.0000 -0.0073
-0.0327
1.3504
Hs 578T
TNBC
Basal B
PD 98059
MEK
MAPK
10694.152
uM
inf
inf
0.8155 0.8155 0.0000 0.0947
0.0324
2.4238
BT-20
TNBC
Basal A
Methotrexate
DHFR
Metabolism
5902.084
uM
inf
inf
0.9945 0.9945 0.0000 -0.0077
-0.0317
1.3532
HCC1569
HER2amp
Basal A
Cetuximab
EGFR
ErbB
7447.102
uM
inf
inf
0.9613 0.9613 0.0000 0.0386
0.0310
1.6467
HCC1395
TNBC
Basal B
FTase Inhibitor I
Ftase
MAPK
12084.154
uM
inf
inf
0.7715 0.7715 0.0000 0.1395
-0.0309
1.2963
CAMA-1
HR+
Luminal
Purvalanol A
CDK1
CDK
5912.067
uM
inf
inf
0.8672 0.8672 0.0000 0.0876
-0.0304
1.1725
CAMA-1
HR+
Luminal
Nilotinib
ABL
nRTK
12070.145
uM
inf
inf
0.8990 0.8990 0.0000 0.1345
0.0301
1.0737